Preclinical research - In vivo - Tracer specificity
4 important questions on Preclinical research - In vivo - Tracer specificity
What is the general idea of blocking studies?
Als er bij een blocking agent nog steeds veel opname is dan weet je dat de opname niet specifiek is.
How can you measure in vivo specificity?
Blocking studies are conducted to evaluate in vivo specificity
- Injecting an increasing amount of competing nonradioactive ligand before, after, or with the radiotracer
- Dose of the competing agent should be below the pharmacological effect of the drug to minimize the pharmacological effect (usually in mg/kg)
- Significant decrease of in the accumulation of the radiotracer (often 50– 75% less than the positive control)
- For small molecule a non structurally related competitor is usually used
What can be used instead of a nonradioactive ligand in blocking studies?
For small molecules;
For peptide tracers;
For antibody radiotracers;
For peptide tracers; scrambled peptides
For antibody radiotracers; isotype control antibody
- Higher grades + faster learning
- Never study anything twice
- 100% sure, 100% understanding
What is important in blocking studies?
The question on the page originate from the summary of the following study material:
- A unique study and practice tool
- Never study anything twice again
- Get the grades you hope for
- 100% sure, 100% understanding

















